HK Stock Market Move | MORIMATSU INTL (02155) up by over 6% again, domestic and foreign pharmaceutical production capacity entering expansion cycle, company's new signed orders rapidly increasing.

MORIMATSU INTL (02155) rose by over 6%, trading at an increase of 5.24% to HK$11.04 at the time of writing, with a trading volume of HK$2164.01 million. Open Source Securities previously released a research report stating that MORIMATSU INTL has been deeply involved in the pressure vessel field for many years, forming solutions that encompass core equipment, process systems, and digitalized factories, covering industries such as pharmaceuticals, chemicals, daily chemicals, energy, and electronic chemicals. The bank pointed out that the downstream industries have high business activity, the pharmaceutical industry is entering a recovery period, overseas MNCs' CAPEX demand is recovering, new orders are growing rapidly, coupled with the release of production capacity at overseas production bases, the engineering cycle is expected to shorten, accelerating the delivery of orders exceeding one hundred billion, driving high-speed performance growth. The bank also pointed out that the explosion of AI technology has generated a massive demand for computing power, urging AI companies to increase their construction speed and delivery capabilities for AIDC. In this context, the delivery model of the AIDC industry chain is accelerating iteration, and prefabricated modular delivery is gradually becoming the standard solution for the construction of the new generation of AIDC. Morimatsu's modular data center business has significant advantages, enabling efficient delivery to meet the demand for computing power.